Sign in

CIK 0000882095

  • Large accelerated filer

GILEAD SCIENCES, INC.

Sign in to watch
Ticker
GILD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943047598
Phone
+1 650-574-3000
Business address
333 LAKESIDE DR, FOSTER CITY, CA, 94404
Former names
GILEAD SCIENCES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$36,996,096
in 12 filings, $37.0M under 10b5-1 plans

Net −$36,996,096. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-03-10 Mercier Johanna Chief Commercial Officer Option exercise +3,025 79,390
2023-03-10 Mercier Johanna Chief Commercial Officer Option exercise +7,951 87,341
2023-03-10 Mercier Johanna Chief Commercial Officer Shares withheld for taxes −5,116 $79.50 $407K 82,225
2023-03-10 Mercier Johanna Chief Commercial Officer Option exercise · Restricted Stock Unit −3,025 47,283
2023-03-10 Mercier Johanna Chief Commercial Officer Option exercise · Restricted Stock Unit −7,951 39,332
2023-03-10 Mercier Johanna Chief Commercial Officer Grant or award · Restricted Stock Unit +16,350 55,682
2023-03-10 Mercier Johanna Chief Commercial Officer Grant or award · Non-qualified Stock Option (Right to Buy) +74,565 74,565
2023-03-10 Dickinson Andrew D Chief Financial Officer Option exercise +3,025 108,643
2023-03-10 Dickinson Andrew D Chief Financial Officer Option exercise +7,394 116,037
2023-03-10 Dickinson Andrew D Chief Financial Officer Shares withheld for taxes −4,849 $79.50 $385K 111,188
2023-03-10 Dickinson Andrew D Chief Financial Officer Option exercise · Restricted Stock Unit −3,025 39,644
2023-03-10 Dickinson Andrew D Chief Financial Officer Option exercise · Restricted Stock Unit −7,394 32,250
2023-03-10 Dickinson Andrew D Chief Financial Officer Grant or award · Restricted Stock Unit +16,350 48,600
2023-03-10 Dickinson Andrew D Chief Financial Officer Grant or award · Non-qualified Stock Option (Right to Buy) +74,565 74,565
2023-03-10 Telman Deborah H EVP, Corporate Affairs & GC Grant or award · Restricted Stock Unit +10,220 43,140
2023-03-10 Telman Deborah H EVP, Corporate Affairs & GC Grant or award · Non-qualified Stock Option (Right to Buy) +46,605 46,605
2023-03-09 Lofton Kevin E Director Option exercise +8,442 $52.38 $442K 8,442
2023-03-09 Lofton Kevin E Director Option exercise · Non-qualified Stock Option (Right to Buy) −8,442 0
2023-03-01 Parsey Merdad Chief Medical Officer Sale −12,984 $79.96 $1.0M 70,130
2023-03-01 O'Day Daniel Patrick Chairman & CEO Option exercise +11,362 364,337

Page 37 of 43 · 851 trades